Login Register Cart 0
Generic placeholder image

Current Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 0929-8673
ISSN (Online): 1875-533X

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Editorial

Cancer Immunotherapy and Immunomodulation

Author(s): Guangdi Wang

Volume 26, Issue 17, 2019

Page: [2988 - 2989] Pages: 2

DOI: 10.2174/092986732617190820123515

« Previous Next »
[1]
Zhao, L.M.; Zhang, J.H., Histone deacetylase inhibitors in tumor immunotherapy. Curr. Med. Chem., 2019, 26, (17), 2990-3008.
[2]
Li, B.; Chan, H.L.; Chen, P., Immune checkpoint inhibitors: basics and challenges. Curr. Med. Chem., 2019, 26, (17), 3009-3025.
[3]
Zhou, W.; Guo, S.; Liu, M.; Burow, M.E.; Wang, G., Targeting CXCL12/CXCR4 axis in tumor immunotherapy. Curr. Med. Chem., 2019, 26, (17), 3026-3041.
[4]
Patanaponpibul, M.; Chen, Q.H., Immune modulation of Asian folk herbal medicines and related chemical components for cancer management. Curr. Med. Chem., 2019, 26, (17), 3042-3067.
[5]
Hao, L.; Li, T.; Chang, L.J.; Chen, X., Adoptive immunotherapy for B-cell malignancies using CD19-targeted chimeric antigen receptor T-cells: A systematic review of efficacy and safety. Curr. Med. Chem, 2019, 26, (17), 3068-3079.

Rights & Permissions Print Cite
Article Metrics
21
2
© 2024 Bentham Science Publishers | Privacy Policy